Neumora Therapeutics Inc. Common Stock
NMRA | NASDAQ
$0.69
-$0.04 (-5.48%)
At close: Sep 21, 2026, 4:00 PM ET
$0.74
+$0.05 (+6.74%)
Pre-market:
Sep 22, 2026, 8:07 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 182.53M | 142.15M | 374.04M | 240.94M | 409.25M | 191.98M |
Short-Term Investments | n/a | 165.43M | 79.94M | 130.94M | n/a | n/a |
Long-Term Investments | n/a | n/a | 9.85M | 23.51M | n/a | n/a |
Other Long-Term Assets | 53K | n/a | 1.21M | 4.13M | 9.65M | 183K |
Receivables | n/a | n/a | 939K | 919K | 200K | 148K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.01M | 6.48M | n/a | 50K | 125K | 125K |
Total Current Assets | 190.54M | 314.06M | 478.28M | 387.96M | 415.6M | 193.84M |
Property-Plant & Equipment | 457K | 2.92M | 6.86M | 10.64M | 4.04M | 3.92M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 510K | 2.92M | 17.92M | 38.28M | 13.69M | 4.11M |
Total Assets | 191.05M | 316.97M | 496.2M | 426.23M | 429.3M | 197.95M |
Account Payables | 3.38M | 3.31M | 337K | 7.15M | 1.64M | 2.4M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 284K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 28.79M | 10.11M | 10.15M | 10.04M | 8.13M | 4.13M |
Total Current Liabilities | 32.45M | 29.89M | 25.11M | 23.7M | 23.28M | 9.37M |
Long-Term Debt | 193K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 54.53M | 22K | 155K | 844.32M | 730.24M | 281.68M |
Total Long-Term Liabilities | 54.73M | 22K | 2.01M | 849.39M | 731.24M | 282.96M |
Total Liabilities | 87.18M | 29.91M | 27.12M | 873.08M | 754.52M | 292.33M |
Total Debt | 477K | 1.85M | 5.23M | 8.44M | 2.05M | 2.05M |
Book Value | 103.87M | 287.06M | 469.08M | -446.85M | -325.22M | -94.38M |
Book Value Per Share | 0.64 | 1.80 | 2.95 | -2.94 | -2.14 | -0.62 |
Common Stock | 17K | 16K | 16K | 3K | 3K | 13K |
Retained Earnings | -1.18B | -947.22M | -703.43M | -467.51M | -336.61M | -99.29M |
Comprehensive Income | n/a | 62K | -76K | -774K | n/a | n/a |
Shareholders Equity | 103.87M | 287.06M | 469.08M | -446.85M | -325.22M | -94.38M |
Total Investments | n/a | 165.43M | 89.79M | 154.45M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NMRA